What Ozempic costs, with dates: $1,027.51 list price, NovoCare self-pay for pens and tablets, the $25 savings offer, Medicare Part D rules and the 2027 price changes.
Fact-checked against FDA labels and official sources; not yet reviewed by a licensed clinician. This page is education, not medical advice. Talk to your doctor before starting, stopping or changing any treatment.
Key takeaways
- Ozempic's list price was $1,027.51 per package for every pen and tablet strength, checked on 2026-10-06.[1]
- NovoCare Pharmacy self-pay was $349 a month for 0.25 to 1 mg pens and $499 for the 2 mg pen, with a $199 introductory price for two fills through December 31, 2026.[2]
- With commercial insurance that covers GLP-1 medicines, the savings offer can bring Ozempic to $25 a month; government beneficiaries are excluded.[2]
- Medicare Part D covers Ozempic for type 2 diabetes; in 2026 out-of-pocket costs for covered Part D drugs are capped at $2,100.[6]
- From 2027, Ozempic's list price drops to $675 a month and Medicare's negotiated price is $274 for a 30-day supply.[5]
In short: Novo Nordisk lists Ozempic at $1,027.51 per package for every pen strength and tablet strength (checked on October 6, 2026). Paying directly through NovoCare Pharmacy without insurance costs $349 a month for the 0.25 mg, 0.5 mg and 1 mg pens and $499 for the 2 mg pen, with a $199 introductory price for new patients’ first two fills of the starting strengths through December 31, 2026; Ozempic tablets cost $149 to $299 a month depending on strength. With commercial insurance that covers it, the savings offer can bring the cost to as little as $25 a month. Medicare Part D plans cover Ozempic for type 2 diabetes under their usual rules, with out-of-pocket drug costs capped at $2,100 in 2026.
Ozempic is FDA approved for adults with type 2 diabetes (blood-sugar control, and lowering heart and kidney risks in certain patients). It is not approved for weight loss; the semaglutide brand approved for weight management is Wegovy (see Ozempic vs Wegovy and Ozempic for weight loss). This page is about cost only. Decisions about any medicine belong with you and a licensed clinician.
Ozempic cost at a glance (checked October 6, 2026)
- $1,027.51list price per package, any pen or tablet strengthNovoCare
- $349 / $499NovoCare Pharmacy self-pay per month: 0.25 to 1 mg pens / 2 mg penNovoCare Pharmacy
- $25lowest monthly cost with commercial insurance that covers it and the savings offerNovoCare Pharmacy
- $675announced list price per month from January 1, 2027Novo Nordisk
Checked on October 6, 2026
Ozempic prices (checked on October 6, 2026)
| How you pay | Product and strength | Price |
|---|---|---|
| List price (before insurance) | Any pen strength (one pen per package) or tablet strength | $1,027.51 per package |
| NovoCare Pharmacy self-pay, new patients | Pen 0.25 mg and 0.5 mg, first 2 monthly fills, through December 31, 2026 | $199 per month |
| NovoCare Pharmacy self-pay | Pen 0.25 mg, 0.5 mg or 1 mg | $349 per month |
| NovoCare Pharmacy self-pay | Pen 2 mg | $499 per month |
| NovoCare Pharmacy self-pay | Tablets (bottle of 30) | $149, $199 or $299 per month, varying by dose |
| Savings offer with commercial insurance that covers GLP-1 medicines | Pens or tablets | As little as $25 per month for up to 3 months per fill (maximum savings $100 a month) |
| Medicare Part D (type 2 diabetes) | As covered by the plan | Plan cost sharing; deductible no more than $615 and out-of-pocket drug costs capped at $2,100 in 2026 |
What affects what you pay
- Strength. The label describes starting at 0.25 mg weekly for four weeks, then 0.5 mg, with further increases to 1 mg and 2 mg at four-week intervals if needed for blood-sugar control. Self-pay prices are the same for 0.25 to 1 mg and higher for 2 mg.
- Pen or tablet. Ozempic tablets are a separate product with different strengths; whether a tablet fits is a prescriber decision.
- Insurance or self-pay. NovoCare says self-pay prescriptions are processed outside insurance, do not count toward deductibles and cannot be applied to out-of-pocket maximums.
- Why it is prescribed. Plans usually cover Ozempic for type 2 diabetes; prescriptions for weight loss alone are off label and are often not covered.
- Where it is filled. NovoCare offers free home delivery or pickup at a local pharmacy using its discount; retail cash prices differ.
Pens or tablets: the price difference
Ozempic now comes as a weekly pen and as a daily tablet (1.5, 4 and 9 mg), both approved for adults with type 2 diabetes. At NovoCare Pharmacy, tablets were $149 to $299 a month depending on the dose, compared with $349 to $499 for pens after the introductory offer, while both have the same $1,027.51 list price. The tablets have their own instructions (taken on an empty stomach with a little water, then waiting before eating), and the label says they cannot be swapped milligram for milligram with Rybelsus, another oral semaglutide for diabetes. Whether a tablet or a pen suits you, and at what strength, is for your prescriber to decide; lower cost alone is not a reason to switch without advice.
The Ozempic savings offer (the “coupon”)
People with commercial insurance that covers GLP-1 medicines may pay as little as $25 for up to a three-month prescription, with a maximum savings of $100 a month. Government beneficiaries are excluded. NovoCare adds that people with government insurance may still use its self-pay prices if they pay outside their insurance. Eligibility rules apply, and Novo Nordisk can change or cancel the program at any time; read the terms at SavingsCardEligibility.com and NovoCarePharmacyTerms.com. Novo Nordisk also runs a patient assistance program through which eligible people may receive medicine at no cost; ask NovoCare (1-888-693-6742) about current eligibility.
Medicare and Ozempic
Medicare Part D plans cover GLP-1 medicines prescribed for type 2 diabetes, heart disease, sleep apnea or MASH under their normal cost sharing, according to KFF. In 2026, Part D deductibles can be no more than $615, and once your out-of-pocket spending on covered drugs reaches $2,100 you pay nothing more for covered drugs that year. The Extra Help program lowers costs further for people with limited income. Medicare is barred by law from covering drugs used for weight loss, and Ozempic is not part of the temporary GLP-1 Bridge, which is for weight management (it covers Wegovy, Zepbound KwikPen and Foundayo).
Medicaid and commercial plans
Medicaid programs must cover drugs approved for treating diabetes, and, since 2024, for cardiovascular disease, according to KFF. That makes Ozempic for type 2 diabetes different from GLP-1 medicines used for obesity, which Medicaid covers only in some states (13 state fee-for-service programs as of January 2026). KFF notes that when GLP-1s are covered, they are typically subject to utilization controls such as prior authorization. Commercial plans also vary: ask whether Ozempic is on your formulary, its tier, whether prior authorization or a trial of another medicine is required first, and what your copay or coinsurance would be. If a claim is denied, you have the right to appeal; our GLP-1 coverage guide explains the steps and deadlines.
What a year of self-pay Ozempic can cost
As an illustration only, using NovoCare Pharmacy’s self-pay prices on October 6, 2026: a new patient who paid $199 for each of the first two monthly fills and then $349 a month for ten fills at 0.25 to 1 mg would spend about $3,888 in a year. At the 2 mg strength the monthly price is $499, or $5,988 for twelve fills. Your prescriber sets your dose; with insurance and the savings offer the cost may be far lower, and on Medicare, Part D’s $2,100 cap limits what you pay for covered drugs in 2026.
Prices changing in 2027
Two changes are scheduled. First, Novo Nordisk announced on February 24, 2026 that the list price of Ozempic, Wegovy and Rybelsus will be $675 a month from January 1, 2027, and said its self-pay prices are not affected. A lower list price matters most to people with high-deductible plans or coinsurance, whose costs are often based on list price. Second, under the Medicare Drug Price Negotiation Program, Medicare’s negotiated price for Ozempic, Rybelsus and Wegovy will be $274 for a 30-day supply in 2027, a 71% discount from the 2024 list price of $959.
| Item | Value |
|---|---|
| List price per package, October 2026 | $1,027.51 |
| Announced list price per month, 2027 | $675 |
| Medicare negotiated price, 30-day supply, 2027 | $274 |
The Medicare negotiated price applies to Part D plans, not to what an individual pays at the counter; your copay depends on your plan.
Source: NovoCare list price; Novo Nordisk press release (February 24, 2026); CMS negotiated prices for 2027 (checked on October 6, 2026)
Ozempic vs Wegovy cost
Even though both are semaglutide, they are priced separately. On October 6, 2026, Wegovy’s list price was $1,349.02 per package, and NovoCare self-pay was $349 a month for most Wegovy pen strengths, $399 for the Wegovy HD pen and $149 to $299 for Wegovy pills. For weight management, Wegovy is the approved brand and is the one on Medicare’s GLP-1 Bridge. Full details: Wegovy cost.
| Item | Ozempic | Wegovy |
|---|---|---|
| List price per package | $1,027.51 | $1,349.02 |
| Self-pay, standard pen strengths | $349 | $349 |
| Self-pay, top pen strength | $499 | $399 |
| Self-pay tablets, lowest | $149 | $149 |
| Self-pay tablets, highest | $299 | $299 |
Top pen strength: Ozempic 2 mg; Wegovy HD 7.2 mg. Approved uses differ: Ozempic for type 2 diabetes, Wegovy for weight management and heart-risk reduction.
Source: NovoCare and NovoCare Pharmacy (Novo Nordisk) (checked on October 6, 2026)
Counterfeits and unapproved copies
Low prices online can be a warning sign. The FDA has found counterfeit Ozempic 1 mg pens in the U.S. supply chain several times (December 2023, April 2025 and December 2025) and advises buying only from state-licensed pharmacies and checking the packaging. The government’s TrumpRx listing for Ozempic shows the same self-pay prices as NovoCare Pharmacy, which is one way to cross-check a price. Compounded semaglutide is not Ozempic and is not FDA approved; the FDA announced on February 21, 2025 that the semaglutide injection shortage was resolved. See compounded GLP-1s.
Ways to lower the cost
- Ask your plan about formulary status, tiers and any prior authorization for type 2 diabetes.
- Use the savings offer if you have commercial coverage; compare with self-pay if you do not.
- On Medicare, check Extra Help, and ask about the Medicare Prescription Payment Plan, which spreads out-of-pocket costs across the year as monthly bills (it does not lower the total).
- Ask about a 90-day supply, which NovoCare Pharmacy offers.
- Use HSA or FSA funds where allowed; the IRS counts prescribed medicines as medical expenses.
- Never stop a diabetes medicine because of cost without talking to your prescriber; ask about other options, including other diabetes medicines.
Related: Ozempic, semaglutide, Mounjaro cost, GLP-1 insurance coverage, the GLP-1 cost comparison tool and the costs hub.
Prices, with the date we checked them
What you pay for Ozempic depends on the strength, pen or tablet, whether it is prescribed for type 2 diabetes (usually covered) or off label for weight (often not), whether you use commercial insurance with the savings offer, Medicare Part D or self-pay, and where it is filled. Self-pay fills do not count toward deductibles. Prices checked on 2026-10-06.
| Option | Price | Amount | Basis | Checked on |
|---|---|---|---|---|
| Ozempic (semaglutide): approved uses and how it differs from Wegovy | Self-pay / cash | 349 USD | per month, pens 0.25 mg, 0.5 mg or 1 mg, NovoCare Pharmacy | October 6, 2026 |
| Ozempic (semaglutide): approved uses and how it differs from Wegovy | Self-pay / cash | 499 USD | per month, 2 mg pen, NovoCare Pharmacy | October 6, 2026 |
| Ozempic (semaglutide): approved uses and how it differs from Wegovy | Self-pay / cash | 199 USD | per month, first 2 fills of 0.25 mg and 0.5 mg for new patients, through 2026-12-31 | October 6, 2026 |
| Ozempic (semaglutide): approved uses and how it differs from Wegovy | With savings program | 25 USD | per month with commercial coverage (max savings $100 a month; government beneficiaries excluded) | October 6, 2026 |
Prices change often and depend on pharmacy, plan and location. Insurance can change what you pay. Every price shows the date we checked it.
Related guides
Wegovy Cost, Coupons and Savings Programs (prices checked monthly)What Wegovy costs, with dates: list price, NovoCare self-pay prices for pens and pills, the $25…
Does Insurance Cover GLP-1s for Weight Loss? (checked quarterly)Does insurance cover GLP-1s for weight loss? Employer data, Medicare rules and the $50 GLP-1 Bridge,…
Weight-Loss Costs: medications, programs and procedures, with datesWhat weight-loss treatments cost, with dates: GLP-1 self-pay prices, programs, procedures, Medicare and insurance, HSA and…
Mounjaro Cost: self-pay price, savings card and Medicare (prices checked monthly)What Mounjaro costs, with dates: $499 LillyDirect self-pay at every strength, the $25 savings card and…Latest research
How to Read a Weight-Loss Study Headline in 5 StepsFive questions to ask before believing a weight-loss headline: who was studied, how many, how long,…
What’s Coming in 2027: Weight-Loss Treatments Awaiting FDA DecisionsWeight-loss treatments awaiting FDA decisions in 2027: CagriSema, retatrutide, survodutide, MariTide and more, with filing dates,…
Fake and Counterfeit Weight-Loss Drugs: How to Spot ThemCounterfeit Ozempic has reached U.S. pharmacies three times. The FDA alerts, what online test buys found,…Questions to ask a professional
- Is Ozempic on my plan's formulary for type 2 diabetes, and which tier?
- Would the savings offer, self-pay or my plan cost me less?
- Would Ozempic tablets or another diabetes medicine cost less and still fit my health?
- If I am on Medicare, do I qualify for Extra Help?
- If cost is a problem, what are my safe options before stopping?
Frequently asked questions
How much does Ozempic cost without insurance?
On 2026-10-06, NovoCare Pharmacy self-pay was $349 a month for the 0.25 mg, 0.5 mg and 1 mg pens and $499 for the 2 mg pen; new patients paid $199 for the first two fills of 0.25 or 0.5 mg through December 31, 2026. Tablets were $149 to $299 a month depending on dose.
What is the list price of Ozempic?
$1,027.51 per package for any pen or tablet strength, according to NovoCare on 2026-10-06. Novo Nordisk has announced a $675 monthly list price from January 1, 2027.
Is there an Ozempic coupon?
The savings offer lets people with commercial insurance that covers GLP-1 medicines pay as little as $25 for up to a 3-month prescription, with a maximum savings of $100 a month. It excludes government beneficiaries.
Does insurance cover Ozempic for weight loss?
Ozempic is approved for type 2 diabetes, and plans usually cover it for that use. Prescribing it for weight loss alone is off label and is often not covered; Wegovy is the semaglutide brand approved for weight management.
Does Medicare cover Ozempic?
Part D plans cover Ozempic for type 2 diabetes with their usual cost sharing. In 2026 the Part D deductible is at most $615 and out-of-pocket costs for covered drugs are capped at $2,100. Ozempic is not on the GLP-1 Bridge, which is for weight management.
Will Ozempic get cheaper?
The list price is set to drop to $675 a month from January 1, 2027, and Medicare's negotiated price for Ozempic, Rybelsus and Wegovy will be $274 for a 30-day supply in 2027. Novo Nordisk says self-pay prices are not affected by the list-price change.
Is Ozempic cheaper than Wegovy?
The list price is lower ($1,027.51 vs $1,349.02 per package on 2026-10-06). Self-pay prices were the same ($349) for most pen strengths; the top strength was $499 for Ozempic 2 mg and $399 for Wegovy HD.
Can people on Medicare use the Ozempic savings offer?
No, government beneficiaries are excluded from the $25 offer. NovoCare says people with government insurance may use its self-pay prices if they pay outside their insurance; that spending would not count toward Part D limits.
References
- Ozempic list price and insurance coverage explained. Novo Nordisk (NovoCare). (accessed October 6, 2026) Other
- Ozempic online pharmacy: self-pay prices and savings. Novo Nordisk (NovoCare Pharmacy). (accessed October 7, 2026) Other
- OZEMPIC (semaglutide) injection: prescribing information. Novo Nordisk, via DailyMed, 2026. (accessed October 7, 2026) Drug label
- Novo Nordisk announces significant reduction in US list price for Wegovy, Ozempic and Rybelsus. Novo Nordisk (press release), 2026. (accessed October 7, 2026) News (reported facts only)
- Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2027. Centers for Medicare and Medicaid Services. (accessed October 6, 2026) Government page
- How much does Medicare drug coverage cost?. Medicare.gov (CMS). (accessed October 6, 2026) Government page
- What Medicare’s Temporary Program Covering GLP-1s for Obesity Means for Beneficiaries. KFF, 2026. (accessed October 6, 2026) Other
- Medicare GLP-1 Bridge: information for providers. Centers for Medicare and Medicaid Services. (accessed October 7, 2026) Government page
- Wegovy at NovoCare Pharmacy: self-pay prices. Novo Nordisk (NovoCare Pharmacy). (accessed October 7, 2026) Other
- Wegovy cost, coverage and savings resources. Novo Nordisk (NovoCare). (accessed October 6, 2026) Other
- FDA warns consumers not to use counterfeit Ozempic found in U.S. drug supply chain. U.S. Food and Drug Administration, 2025. (accessed October 7, 2026) Government page
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (content current as of 2026-04-01). U.S. Food and Drug Administration. (accessed October 6, 2026) Government page
- Ozempic pen on TrumpRx. TrumpRx.gov (U.S. government). (accessed October 6, 2026) Government page
- Medicare Prescription Payment Plan. Medicare.gov (CMS). (accessed October 6, 2026) Government page
- Medicaid Coverage of and Spending on GLP-1s. KFF, 2026. (accessed October 6, 2026) Other
- RYBELSUS and OZEMPIC (semaglutide) tablets: prescribing information. Novo Nordisk, via DailyMed. (accessed October 6, 2026) Drug label
- Publication 502 (2025), Medical and Dental Expenses. Internal Revenue Service, 2025. (accessed October 6, 2026) Government page
Facts checked on October 6, 2026
Educational information, not medical advice. Talk with a qualified healthcare professional about your own situation. In an emergency call 911.